Alteplase 100MG VI 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FAWNT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $91,684
Award facts
- Contract value 100% obligated
- $91,684.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Alteplase 100 mg intravenous solution with a ceiling value of $91,684.08 under firm fixed pricing.
Place of performance is Conshohocken, PA. Ultimate completion date is March 10, 2026. The order carries no set-aside designation.
Quick answers
Who was awarded contract SPE2DR26FAWNT?
SPE2DR26FAWNT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 9, 2026.
How much is contract SPE2DR26FAWNT worth?
The government has obligated $91,684 on SPE2DR26FAWNT.
Is contract SPE2DR26FAWNT an order under another contract?
Yes. SPE2DR26FAWNT is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAWNT competed?
The extent of competition for SPE2DR26FAWNT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award